Show simple item record

dc.contributor.authorHalamoda-Kenzaoui, Blanka
dc.contributor.authorGeertsma, Robert
dc.contributor.authorPouw, Joost
dc.contributor.authorPrina-Mello, Adriele
dc.contributor.authorCarrer, Moreno
dc.contributor.authorRoesslein, Matthias
dc.contributor.authorSips, Adrienne
dc.contributor.authorWeltring, Klaus Michael
dc.contributor.authorSpring, Kathleen
dc.contributor.authorBremer-Hoffmann, Susanne
dc.date.accessioned2022-06-14T10:02:55Z
dc.date.available2022-06-14T10:02:55Z
dc.date.issued2022-06-12
dc.identifier.pmid35691982
dc.identifier.doi10.1007/s13346-022-01165-y
dc.identifier.urihttp://hdl.handle.net/10029/625836
dc.language.isoenen_US
dc.rights© 2022. The Author(s).
dc.subjectHarmonisationen_US
dc.subjectMethod standardisationen_US
dc.subjectNanomedical devicesen_US
dc.subjectNanomedicineen_US
dc.subjectRegulationen_US
dc.titleFuture perspectives for advancing regulatory science of nanotechnology-enabled health products.en_US
dc.typeArticleen_US
dc.identifier.eissn2190-3948
dc.identifier.journalDrug delivery and translational research 2022; 12(9):2145-2156en_US
dc.source.journaltitleDrug delivery and translational research
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record